FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry, namely to composition for stimulating regeneration of damaged liver as a result of hepatectomy. Pharmaceutical composition for stimulating regeneration of damaged liver as a result of hepatectomy, contains: proanthocyanindin in effective quantity, with monomer units of proanthocyanidin having the following formula: in which when R1 represents OCH3, R2 represents OH and R3 represents H, when R1 represents OH, R2 represents H and R3 represents H, when R1 represents OH, R2 represents OH and R3 represents H, or when R1 represents OH, R2 represents OH and R3 represents OH, and R4 represents 3-(α)-OH, 3-(β)-OH, 3-(α)-O-sugar or 3-(β)-O-sugar; and pharmaceutically acceptable carrier or salt, where pharmaceutically acceptable salt is selected from the group, consisting of inorganic salts of sodium, potassium, amine, magnesium, calcium, zinc, aluminium or zirconium, and organic salts of dicyclohexylamine, methyl-d-glycamine, arginine, lysine, histidine or glutamine.
EFFECT: composition is effective for stimulating regeneration of damaged liver as a result of hepatectomy.
10 cl, 17 dwg, 3 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR INHIBITING AUTOPHAGY OF MOTOR NEURONS AND USE THEREOF | 2012 |
|
RU2585372C1 |
NEW DRUG FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS AND FIBROSIS | 2017 |
|
RU2762280C2 |
NEW COMPOUNDS | 2019 |
|
RU2812934C2 |
PHARMACEUTICAL COMPOSITION BASED ON HAEE PEPTIDE FOR TREATING NEURODEGENERATIVE DISEASES | 2019 |
|
RU2709539C1 |
CANCER MODELS AND CORRESPONDING METHODS | 2014 |
|
RU2707531C2 |
PHOSPHORUS(N)AMIDATEACETAL AND PHOSPH(OH)ATACETAL COMPOUNDS | 2019 |
|
RU2796403C2 |
APPLICATION OF CB1 RECEPTOR ANTAGONISTS FOR PREPARATION OF COMPOSITION APPLICABLE FOR TREATMENT OF HEPATIC DISEASES | 2005 |
|
RU2402328C2 |
PTERIDINES EFFECTIVE AS HCV INHIBITORS AND METHODS FOR PRODUCING PTERIDINES | 2006 |
|
RU2447074C2 |
ADVANCED COMPOUND FOR THE TREATMENT OF HEART FAILURE | 2018 |
|
RU2794975C2 |
MONOCLONAL ANTIBODIES AGAINST CLAUDIN 1 FOR PREVENTION AND TREATMENT OF HEPATOCELLULAR CARCINOMA | 2016 |
|
RU2770021C2 |
Authors
Dates
2015-08-27—Published
2011-03-22—Filed